Dr Ilya Liz Arriaga, OD in St.. Chroix, VI - Optometrist

Dr Ilya Liz Arriaga, OD is a Optometrist based in St.. Chroix, Virgin Island. Dr Ilya Liz Arriaga is licensed to practice in Virgin Island (license number 00) and her current practice location is Golden Rock Mall, St.. Chroix, Virgin Island. She can be reached at her office (for appointments etc.) via phone at (340) 773-8520.

NPI number for Dr Ilya Liz Arriaga is 1346448982 and her current mailing address is Golden Rock Mall, St. Chroix, Virgin Island. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346448982.

Contact Information

	Dr Ilya Liz Arriaga, OD
	Golden Rock Mall, St.. Chroix, VI 00820
	(340) 773-8520
	Not Available

Healthcare Provider's Profile

Full Name	Dr Ilya Liz Arriaga
Gender	Female
Speciality	Optometrist
Location	Golden Rock Mall, St.. Chroix, Virgin Island
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346448982
Provider Enumeration Date: 07/05/2007
Last Update Date: 02/08/2010

Medical Identifiers

Medical identifiers for Dr Ilya Liz Arriaga such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346448982	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	00 (Virgin Island)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ilya Liz Arriaga is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ilya Liz Arriaga, OD Golden Rock Mall, St. Chroix, VI 00820 Ph: () -	Dr Ilya Liz Arriaga, OD Golden Rock Mall, St.. Chroix, VI 00820 Ph: (340) 773-8520

News Archive

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.

COVID-19 infection risk and outcomes explained by the cell receptor genetic variability

Genetic variants in the angiotensin‐converting enzyme 2 (ACE2) receptor, utilized by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for cell entry, are predicted to either encourage or inhibit interaction with viral proteins and subsequently contribute to genetic risk in coronavirus disease (COVID-19). This is the key finding of a new study available on the preprint server bioRxiv*.

Daclizumab effective at reducing organ rejection and risk of infection in heart transplant patients

A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.

Toxic protein in bee venom improves liposome encapsulated drug effectiveness

The next time you are stung by a bee, here's some consolation: a toxic protein in bee venom, when altered, significantly improves the effectiveness liposome-encapsulated drugs or dyes, such as those already used to treat or diagnose cancer. This research, described in the August 2010 print issue of the FASEB Journal, shows how modified melittin may revolutionize treatments for cancer and perhaps other conditions, such as arthritis, cardiovascular disease, and serious infections.

Live malaria parasites in the skin shut down immune responses and block vaccine function: Study

Why one after another new malaria vaccine tests well in the laboratory but fails in field trials has frustrated legions of malaria researchers, and has been the main stumbling block to malaria eradication. Now, a research team from Germany has unraveled that puzzle and shown that the problem is all about the skin and how it controls the immune system. The implications are profound.

Dr Ilya Liz Arriaga, OD - Optometrist in St.. Chroix, VI